Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma.
Biomarker
Calprotectin
Cancer
Inflammation
S100A12
S100A8/A9
Transitional cell carcinoma
Tumor immunology
Urinary tract infection
Urolithiasis
Journal
BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759
Informations de publication
Date de publication:
21 Nov 2022
21 Nov 2022
Historique:
received:
01
06
2022
accepted:
10
11
2022
entrez:
21
11
2022
pubmed:
22
11
2022
medline:
24
11
2022
Statut:
epublish
Résumé
Urothelial carcinoma (UC) is the most common neoplasm of the canine lower urinary tract, affecting approximately 2% of dogs. Elderly female patients of certain breeds are predisposed, and clinical signs of UC can easily be confused with urinary tract infection or urolithiasis. Diagnosis and treatment are challenging given the lack of disease-specific markers and treatments. The S100A8/A9 complex and S100A12 protein are Ca Tissue S100A12-positive cell counts were significantly higher in dogs with lower urinary tract disease than healthy controls (P = 0.0267 for UC, P = 0.0049 for NNUTD), with no significant difference between UC and NNUTD patients. Tissue S100A8/A9-positivity appeared to be higher with NNUTD than UC, but this difference did not reach statistical significance. The S100A8/A9 These results confirm that the S100/calgranulins play a role in the immune response to inflammatory and neoplastic lower urinary tract diseases in dogs, but the tissue expression of these proteins appears to differ from their concentrations reported in urine samples. Further investigations of the S100/calgranulin pathways in UC and their potential as diagnostic or prognostic tools and potential therapeutic targets are warranted. The NLR as a routinely available marker might be a useful surrogate to distinguish UC from inflammatory conditions.
Sections du résumé
BACKGROUND
BACKGROUND
Urothelial carcinoma (UC) is the most common neoplasm of the canine lower urinary tract, affecting approximately 2% of dogs. Elderly female patients of certain breeds are predisposed, and clinical signs of UC can easily be confused with urinary tract infection or urolithiasis. Diagnosis and treatment are challenging given the lack of disease-specific markers and treatments. The S100A8/A9 complex and S100A12 protein are Ca
RESULTS
RESULTS
Tissue S100A12-positive cell counts were significantly higher in dogs with lower urinary tract disease than healthy controls (P = 0.0267 for UC, P = 0.0049 for NNUTD), with no significant difference between UC and NNUTD patients. Tissue S100A8/A9-positivity appeared to be higher with NNUTD than UC, but this difference did not reach statistical significance. The S100A8/A9
CONCLUSIONS
CONCLUSIONS
These results confirm that the S100/calgranulins play a role in the immune response to inflammatory and neoplastic lower urinary tract diseases in dogs, but the tissue expression of these proteins appears to differ from their concentrations reported in urine samples. Further investigations of the S100/calgranulin pathways in UC and their potential as diagnostic or prognostic tools and potential therapeutic targets are warranted. The NLR as a routinely available marker might be a useful surrogate to distinguish UC from inflammatory conditions.
Identifiants
pubmed: 36411489
doi: 10.1186/s12917-022-03513-z
pii: 10.1186/s12917-022-03513-z
pmc: PMC9680134
doi:
Substances chimiques
Leukocyte L1 Antigen Complex
0
S100A12 Protein
0
Calgranulin A
0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
412Informations de copyright
© 2022. The Author(s).
Références
J Comp Pathol. 1995 Aug;113(2):113-30
pubmed: 8543669
Clin Cancer Res. 2005 Jul 15;11(14):5146-52
pubmed: 16033829
Can Vet J. 2011 Sep;52(9):1013-7
pubmed: 22379204
J Vet Intern Med. 2015 May-Jun;29(3):828-33
pubmed: 25940672
J Am Vet Med Assoc. 2012 Dec 15;241(12):1627-32
pubmed: 23216038
Clin Cancer Res. 2003 Feb;9(2):906-11
pubmed: 12576466
Oncotarget. 2018 Dec 11;9(97):37042-37053
pubmed: 30651934
Eur Urol Open Sci. 2021 Dec 23;36:26-33
pubmed: 35098169
Front Oncol. 2021 Dec 02;11:762470
pubmed: 34926263
Respir Med. 2008 Apr;102(4):567-73
pubmed: 18164192
Clin Immunol. 1999 Apr;91(1):34-40
pubmed: 10219252
Res Vet Sci. 2007 Oct;83(2):210-6
pubmed: 17316722
J Am Vet Med Assoc. 2007 Oct 1;231(7):1056-60
pubmed: 17916030
J Vet Intern Med. 1992 May-Jun;6(3):145-53
pubmed: 1619591
PLoS One. 2019 Mar 14;14(3):e0213549
pubmed: 30870488
J Vet Diagn Invest. 2021 May;33(3):516-527
pubmed: 33554784
J Vet Intern Med. 1997 Sep-Oct;11(5):279-83
pubmed: 9348494
Vet Clin North Am Small Anim Pract. 2003 May;33(3):573-96
pubmed: 12852237
J Vet Intern Med. 2011 Nov-Dec;25(6):1385-90
pubmed: 22092632
J Vet Emerg Crit Care (San Antonio). 2022 Jan;32(1):83-89
pubmed: 34800354
Vet Clin Pathol. 2016 Mar;45(1):135-47
pubmed: 26765807
Tierarztl Prax Ausg K Kleintiere Heimtiere. 2018 Oct;46(5):289-295
pubmed: 30541168
J Vet Intern Med. 2013 Jan-Feb;27(1):126-33
pubmed: 23205923
J Am Vet Med Assoc. 2005 Jul 1;227(1):94-100
pubmed: 16013542
Cell. 1999 Jun 25;97(7):889-901
pubmed: 10399917
J Am Vet Med Assoc. 2004 Apr 15;224(8):1290-7
pubmed: 15112777
Urol Oncol. 2000 Mar-Apr;5(2):47-59
pubmed: 21227289
J Vet Diagn Invest. 2014 Jan;26(1):104-12
pubmed: 24398905
J Am Anim Hosp Assoc. 2019 Sep/Oct;55(5):243-248
pubmed: 31433219
Acta Oncol. 2021 Jun;60(6):704-713
pubmed: 33586577
J Small Anim Pract. 2016 Mar;57(3):135-41
pubmed: 26712718
Int J Chronic Dis. 2013;2013:578613
pubmed: 26464846
J Leukoc Biol. 2009 Sep;86(3):557-66
pubmed: 19451397
Mol Med Rep. 2015 Jun;11(6):4093-100
pubmed: 25673070
J Natl Cancer Inst. 1969 Dec;43(6):1249-61
pubmed: 4319248
Am J Vet Res. 2000 May;61(5):478-81
pubmed: 10803639
J Toxicol Environ Health. 1989;28(4):407-14
pubmed: 2593174
J Vet Intern Med. 2018 Jan;32(1):370-376
pubmed: 29080252
J Am Vet Med Assoc. 2013 Jun 1;242(11):1534-8
pubmed: 23683018
PLoS One. 2015 Dec 09;10(12):e0144170
pubmed: 26649430
Turk Thorac J. 2016 Apr;17(2):41-46
pubmed: 29404122
Vet Sci. 2019 Mar 19;6(1):
pubmed: 30893857
J Vet Emerg Crit Care (San Antonio). 2021 Jul;31(4):490-497
pubmed: 33960611
Vet J. 2015 Aug;205(2):217-25
pubmed: 25747698
Vet Comp Oncol. 2018 Dec;16(4):642-649
pubmed: 30246405
Vet Med Sci. 2021 Jul;7(4):1131-1143
pubmed: 33751838
Bratisl Lek Listy. 2001;102(1):5-14
pubmed: 11723675
Am J Vet Res. 2013 Dec;74(12):1474-80
pubmed: 24274883
Oncotarget. 2018 Apr 10;9(27):19026-19038
pubmed: 29721181
Oncol Lett. 2018 Oct;16(4):5398-5404
pubmed: 30250610
ILAR J. 2014;55(1):100-18
pubmed: 24936033
J Am Vet Med Assoc. 2004 Aug 1;225(3):389-94
pubmed: 15328714
Vet Comp Oncol. 2005 Jun;3(2):73-80
pubmed: 19379215
J Cell Biochem. 2010 Jun 1;110(3):645-59
pubmed: 20512925
Asian Pac J Cancer Prev. 2015;16(7):2725-9
pubmed: 25854354
Pharmacol Rev. 2004 Sep;56(3):387-437
pubmed: 15317910
Ann Oncol. 2014 May;25(5):974-9
pubmed: 24631944
Res Vet Sci. 2019 Oct;126:150-154
pubmed: 31493682
Cancer. 1953 Sep;6(5):963-8
pubmed: 13094644
Proc Soc Exp Biol Med. 2000 Jan;223(1):22-38
pubmed: 10632958
Am J Vet Res. 2003 Aug;64(8):1017-20
pubmed: 12926595
J Vet Intern Med. 2010 Sep-Oct;24(5):1124-30
pubmed: 20695986
J Am Vet Med Assoc. 2011 Oct 15;239(8):1084-9
pubmed: 21985349
Vet Radiol Ultrasound. 2002 Jan-Feb;43(1):50-3
pubmed: 11866046
BMC Vet Res. 2017 Apr 21;13(1):112
pubmed: 28431528
Vet Comp Oncol. 2015 Dec;13(4):337-47
pubmed: 23786518
J Biol Chem. 2008 May 9;283(19):13035-43
pubmed: 18292089
PLoS One. 2015 Jun 08;10(6):e0129534
pubmed: 26053201
Adv Ther. 2018 Nov;35(11):2054-2068
pubmed: 30232708
Biochimie. 2008 Sep;90(9):1306-15
pubmed: 18405670
Investig Clin Urol. 2021 Nov;62(6):641-649
pubmed: 34729964
J Am Vet Med Assoc. 2011 Aug 1;239(3):350-6
pubmed: 21801049
Prostaglandins Leukot Essent Fatty Acids. 2005 Mar;72(3):181-6
pubmed: 15664302
BMC Cancer. 2010 Jan 25;10:21
pubmed: 20096140
J Am Vet Med Assoc. 2006 Jul 15;229(2):226-34
pubmed: 16842042
J Vet Intern Med. 1994 Jul-Aug;8(4):273-8
pubmed: 7983623
J Vet Intern Med. 2003 Mar-Apr;17(2):136-44
pubmed: 12683611
BMC Vet Res. 2018 Mar 12;14(1):84
pubmed: 29530040
World J Urol. 2014 Dec;32(6):1485-92
pubmed: 24378824